[1]
Miró, M. 2009. ¿Se acerca el fin de la succinilcolina? Estudio dosis-respuesta de Sugammadex: Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS. Anesthesiology 2008; 109 (2): 188-97. Revista Electrónica AnestesiaR. 1, 10 (oct. 2009), 1. DOI:https://doi.org/10.30445/rear.v1i10.585.